Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

49
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
49
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

51
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
51
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

28
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
28

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Postmyocardial infarction ventricular septal defect outcomes: Partial versus full presurgical hemodynamic support.

JTCVS open·2026
Same author

Impact of aortic root surgery during transcatheter aortic valve explant.

JTCVS structural and endovascular·2026
Same author

Iliac artery involvement determines optimal therapy in acute uncomplicated type B aortic dissection.

JTCVS structural and endovascular·2026
Same author

Endovascular arch repair using a novel single branch arch stent graft: 30-Day results from the chronic dissection arm of the NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness investigational device exemption study.

JTCVS structural and endovascular·2026
Same author

Don't let patient-prosthesis mismatch cramp your style: Stentless root replacement for the small aortic annulus.

JTCVS structural and endovascular·2026
Same author

Reply: VSRR-Not better operation or patient selection, but better operation in selected patients.

The Journal of thoracic and cardiovascular surgery·2026

相关实验视频

Updated: Sep 16, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K

门节约性根部更换:多大年龄是太老了吗?

Elizabeth L Norton1, Yanhua Wang2, Parth M Patel1

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Ga.

JTCVS open
|July 9, 2025
PubMed
概括

节能根置换 (VSRR) 显示出良好的结果,但老年患者 (65岁以上) 面临更高的死亡率. 65岁以上的年龄是晚期死亡的风险因素,尽管重新手术率仍然相似. 建议对老年患者进行仔细考虑.

关键词:
大动脉的动脉.大动脉根替代术门节约性大动脉根置换术

更多相关视频

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

3.2K

相关实验视频

Last Updated: Sep 16, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

3.2K

科学领域:

  • 心血管外科心血管外科
  • 大动脉根部外科手术
  • 老年心脏病学 老年心脏病学

背景情况:

  • 节约根部更换 (VSRR) 提供了优秀的短期和长期效果.
  • 虽然通常在年轻的患者中进行,但VSRR在广泛的年龄范围内使用,包括70多岁的个人.
  • 年龄和并发症对VSRR结果的影响需要进一步调查.

研究的目的:

  • 分析年龄和手术前并发症对VSRR后手术结果的影响.
  • 评估年龄对复手率和VSRR后的存活率的影响.
  • 根据长期存活数据,确定VSRR的最佳年龄截止值.

主要方法:

  • 在2004年至2021年期间接受VSRR治疗的780名患者的回顾性分析.
  • 使用大卫V再植入技术进行了VSRR.
  • 根据65岁的年龄截止值,患者被分为两组,使用Contal和O'Quigley方法确定.

主要成果:

  • 65岁的年龄截止被认为是最佳的;16%的患者≥65岁.
  • 在65岁以上的患者中,住院死亡率更高 (4.1%对1.1%,P=.03).
  • 65岁以上的患者的十年生存率显著下降 (76%与92%相比,P<.0001),65岁以上的年龄是晚期死亡的独立风险因素.

结论:

  • 在各个年龄组中,VSRR可以执行,手术死亡率低,并且无需重新手术.
  • 65岁及以上接受VSRR治疗的患者需要仔细考虑,特别是在主动脉剖析的情况下.
  • 年龄≥65岁是VSRR后晚期死亡的一个独立风险因素.